Use of calcimimetics in children with normal kidney function
- PMID: 29552709
- DOI: 10.1007/s00467-018-3935-1
Use of calcimimetics in children with normal kidney function
Abstract
The calcium-sensing receptor (CaSR) plays an important role in the homeostasis of serum ionized calcium by regulating parathyroid hormone (PTH) secretion and tubular calcium handling. Calcimimetics, which act by allosteric modulation of the CaSR, mimic hypercalcemia resulting in suppression of PTH release and increase in calciuria. Mostly used in children to treat secondary hyperparathyroidism associated with advanced renal failure, we have shown that calcimimetics can also be successfully used in children with bone and mineral disorders in which elevated PTH plays a detrimental role in skeletal pathophysiology in the face of normal kidney function. The current review briefly discusses the role of the CaSR and calcimimetics in calcium homeostasis, and then addresses the potential applications of calcimimetics in children with normal kidney function with disorders in which suppression of PTH is beneficial.
Keywords: Calcimimetics; Calcium-sensing receptor; Hyperparathyroidism; Parathyroid hormone; Rickets.
Similar articles
-
Calcimimetics and hyperparathyroidism.Curr Opin Investig Drugs. 2004 Oct;5(10):1080-5. Curr Opin Investig Drugs. 2004. PMID: 15535429 Review.
-
Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders.Best Pract Res Clin Endocrinol Metab. 2013 Jun;27(3):373-84. doi: 10.1016/j.beem.2013.02.008. Epub 2013 Mar 27. Best Pract Res Clin Endocrinol Metab. 2013. PMID: 23856266 Review.
-
Discovery of a calcimimetic with differential effects on parathyroid hormone and calcitonin secretion.J Pharmacol Exp Ther. 2011 Jun;337(3):681-91. doi: 10.1124/jpet.110.178681. Epub 2011 Mar 21. J Pharmacol Exp Ther. 2011. PMID: 21422163
-
Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration.Kidney Int. 2019 May;95(5):1064-1078. doi: 10.1016/j.kint.2018.12.015. Epub 2019 Mar 12. Kidney Int. 2019. PMID: 30878213
-
Recent updates on the calcium-sensing receptor as a drug target.Curr Med Chem. 2008;15(2):178-86. doi: 10.2174/092986708783330601. Curr Med Chem. 2008. PMID: 18220773 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources